IMCYSE

Imcyse is a clinical stage biopharmaceutical company pioneering the development of a new class of active specific immunotherapies for the treatment of severe chronic autoimmune diseases. The company’s unique technology platform allows it to locally target immune cells involved in the destruction of the diseased organ. This platform is based on the administration of Imotopes™, which are specifically modified peptides, allowing for the generation of cytolytic CD4 T-cells, that specifically eli... minate antigen-presenting cells and autoantigen specific lymphocytes. Imcyse’s approach, sustained over time, helps to prevent and treat diseases with no current therapeutic alternative and to potentially cure patients without impairing immune defense. The company has established proof of concept in several indications and has completed its first clinical trial in type 1 diabetes with promising results. Beyond type 1 diabetes, Imcyse is developing a pipeline of Imotopes™ for the treatment of several autoimmune diseases.

#People #Financial #Website #More

IMCYSE

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2010-01-01

Address:

Liège, Liege, Belgium

Country:

Belgium

Website Url:

http://www.imcyse.com

Total Employee:

11+

Status:

Active

Total Funding:

55.9 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Apache Euro

Current Employees Featured

vincent-carlier_image

Vincent Carlier
Vincent Carlier Co-Founder & Research & Development Director, Immunology @ Imcyse
Co-Founder & Research & Development Director, Immunology

denis-bedoret_image

Denis Bedoret
Denis Bedoret Chief Executive Officer @ Imcyse
Chief Executive Officer
2020-09-01

andrew-mackie_image

Andrew Mackie
Andrew Mackie Vice President Of Business Development @ Imcyse
Vice President Of Business Development
2020-07-01

gene-mack_image

Gene Mack
Gene Mack Chief Financial Officer @ Imcyse
Chief Financial Officer
2021-11-01

jean-van-rampelbergh_image

Jean Van Rampelbergh
Jean Van Rampelbergh VP Clinical & Regulatory @ Imcyse
VP Clinical & Regulatory
2020-01-01

antoon-van-oosterhout_image

Antoon van Oosterhout
Antoon van Oosterhout VP R&D - CSO @ Imcyse
VP R&D - CSO
2020-01-01

Founder

vincent-carlier_image

Vincent Carlier

Investors List

biogenosis_image

Official Site Inspections

http://www.imcyse.com Semrush global rank: 2.8 M Semrush visits lastest month: 5.78 K

Host Informations
Whois Informations

Loading ...